Stock Events

Stock Events

Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q1 2022 Earnings

27AprExpected

Q2 2021

Q3 2021

Q4 2021

Q1 2022

-0.02

0.03

0.07

0.11

Details

Expected EPS

N/A

Actual EPS

-0.0168

Surprise EPS

-0.02

Surprise Percent

+∞%

Description

Chengdu Olymvax Biopharmaceuticals (688319.SHG) has reported earnings of -0.0168 per share for Q1 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.